Evidence map›Paper›PMID 25793577›Full record

ReviewCell adhesion & migration2015

Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Alexander Berndt, Petra Richter, Hartwig Kosmehl, Marcus Franz

Open access · goldAbstract readReview
In one paragraph

Review in Cell adhesion & migration, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Tenascin CNature communications · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. 3D Tumor Models in Urology.International journal of molecular sciences · 2023
    Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. The microbiome in urological diseases.Investigative and clinical urology · 2020
    Review
  16. Review
  17. Article
  18. Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.Journal of the American Society of Nephrology : JASN · 2017
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alexander Berndta Institute of Pathology; Jena University Hospital ; Jena , Germany.
Petra Richter
Hartwig Kosmehl
Marcus Franz
Jena University Hospital · DEHelios Klinikum Erfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinoma invasion is a complex process regulated by genetic and epigenetic factors as well. A relevant supportive condition for cancer cell migration is the reorganization of the extracellular matrix (ECM), which is realized in an orchestrated multicellular manner including carcinoma cells and stromal fibroblasts. An important key player in the process of ECM reorganization is Tenascin-C (Tn-C). The molecule occurs as different isoforms generated by alternative splicing and de novo glycosylation. Large variants of Tn-C are abundantly re-expressed in the invasive front of many carcinoma types. A special role for initiating migration and accompanied epithelial to mesenchymal transition has been suggested. Here, we review the current knowledge concerning the tumor biological importance of Tn-C, the synthesis and alternative splicing during the invasive process in general, and give an overview on the impact of Tn-C in urothelial carcinoma of the urinary bladder (UBC) and oral squamous cell carcinoma (OSCC).

Indexed as

AnimalsCarcinoma, Squamous CellCell MovementEpithelial-Mesenchymal TransitionExtracellular MatrixHumansTenascinUrinary Bladder NeoplasmsTenascin3D, 3 dimensionalalternative splicingBM, basement membaneCAF, cancer associated fibroblastcarcinoma invasionECM, extracellular matrixECM reorganizationEMT, epithelial – mesenchymal transitionFGF2, fibroblast growth factor 2Fn, fibronectinFNIII, fibronectin type III like repeatshnRNPs, heterogeneous nuclear ribonucleoproteinsLn, lamininLnγ2, laminin gamma 2 chainMMP, matrix metalloproteinasemRNA, messenger RNAoncFn, oncofetal fibronectinoncTn-C, oncofetal tenascin-Coral squamous cell carcinomaOSCC, oral squamous cell carcinomaPDGF, platelet derived growth factorRNA, ribonucleic acidtenascin-CTGFβ1, transforming growth factor beta 1Tn-C, tenascin-CTPA, tetradecanoylphorbol acetateUBC, urothelial carcinoma of the urinary bladderurothelial carcinoma of the urinary bladder

Identifiers

PMID25793577
PMCPMC4422813
OpenAlexW1532402805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.